Dong X - Search Results

1

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.

Yan H, Song L, Li Y, Xu Q, Guo W, Lin S, Jiang W, Wang Z, Deng L, Huang Z, Qin H, Zhang X, Tong F, Zhang R, Liu Z, Zhang L, Yu J, Dong X, Gong Q, Deng J, Chen X, Wang J, Zhang G, Yang N, Zhang Y, Zeng L. Yan H, et al. Among authors: dong x. Cancer Immunol Immunother. 2024 Mar 7;73(4):74. doi: 10.1007/s00262-024-03660-2. Cancer Immunol Immunother. 2024. PMID: 38451314 Free PMC article.

2

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer.

Zhou R, Tong F, Zhang Y, Zhang R, Bin Y, Zhang S, Yang N, Dong X. Zhou R, et al. Among authors: dong x. Front Oncol. 2023 Nov 9;13:1231094. doi: 10.3389/fonc.2023.1231094. eCollection 2023. Front Oncol. 2023. PMID: 38023206 Free PMC article.

3

Ionizing radiation induces vascular smooth muscle cell senescence through activating NF-κB/CTCF/p16 pathway.

Zheng X, Liu Z, Bin Y, Wang J, Rao X, Wu G, Dong X, Tong F. Zheng X, et al. Among authors: dong x. Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):166994. doi: 10.1016/j.bbadis.2023.166994. Epub 2023 Dec 21. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38141838

4

Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization.

Liu L, Wang J, Wang Y, Chen L, Peng L, Bin Y, Ding P, Zhang R, Tong F, Dong X. Liu L, et al. Among authors: dong x. J Exp Clin Cancer Res. 2024 Apr 29;43(1):128. doi: 10.1186/s13046-024-03024-9. J Exp Clin Cancer Res. 2024. PMID: 38685050 Free PMC article.

5

Retraction Notice to: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.

Chen X, Wang Z, Tong F, Dong X, Wu G, Zhang R. Chen X, et al. Among authors: dong x. Mol Ther Nucleic Acids. 2024 May 18;35(2):102215. doi: 10.1016/j.omtn.2024.102215. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38784179 Free PMC article.

6

Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study.

Huang Z, Zhang Y, Xu Q, Song L, Li Y, Guo W, Lin S, Jiang W, Wang Z, Deng L, Qin H, Zhang X, Tong F, Zhang R, Liu Z, Zhang L, Yu J, Dong X, Gong Q, Deng J, Chen X, Wang J, Zhang G, Yang N, Zeng L, Zhang Y. Huang Z, et al. Among authors: dong x. Lung Cancer. 2024 Jun;192:107827. doi: 10.1016/j.lungcan.2024.107827. Epub 2024 May 21. Lung Cancer. 2024. PMID: 38795459

7

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS).

Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J, Chen S, Lv D, Zhang G, Liu C, Li J, Yu X, Lin Z, Yu Z, Wang Z, Cui J, Xu X, Fang J, Feng J, Xu Z, Ma R, Hu J, Yang N, Zhou X, Wu X, Hu C, Zhang Z, Lu Y, Hu Y, Jiang L, Wang Q, Guo R, Zhou J, Li B, Hu C, Tong W, Zhang H, Ma L, Chen Y, Jie Z, Yao Y, Zhang L, Weng J, Li W, Xiong J, Ye X, Duan J, Yang H, Sun M, Wei H, Wei J, Zhang Z, Wu Q. Lu S, et al. Among authors: dong x. Cancer Commun (Lond). 2024 Sep;44(9):1005-1017. doi: 10.1002/cac2.12594. Epub 2024 Jul 17. Cancer Commun (Lond). 2024. PMID: 39016053 Free PMC article. Clinical Trial.

8

The role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study.

Chen L, Kong Y, Tong F, Zhang R, Ding P, Zhang S, Wang Y, Zhou R, Pu X, Chen B, Liang F, Tan Q, Xu Y, Wu L, Dong X. Chen L, et al. Among authors: dong x. Chin Med J (Engl). 2024 Sep 23. doi: 10.1097/CM9.0000000000003283. Online ahead of print. Chin Med J (Engl). 2024. PMID: 39307928

9

Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics.

Qin H, Huang Z, Yan H, Song L, Zeng L, Xu Q, Guo W, Lin S, Jiang W, Wang Z, Deng L, Zhang X, Tong F, Zhang R, Liu Z, Zhang L, Dong X, Yang N, Zhang Y. Qin H, et al. Among authors: dong x. iScience. 2024 Sep 10;27(10):110910. doi: 10.1016/j.isci.2024.110910. eCollection 2024 Oct 18. iScience. 2024. PMID: 39351193 Free PMC article.

10

Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study.

Zhou Q, Yang N, Zhao M, Huang D, Zhao J, Yu Y, Yuan Y, Sun L, Dong X, Zhang T, Chu Q, Li X, Meng X, Wang H, Wang X, Wu D, Hu S, Shan J, Liu L, Sun M, Zhang Z, Zhu H, Huang J, Huang M, Cheng L, Zhang S, Zhou H, Wu YL. Zhou Q, et al. Among authors: dong x. Eur J Cancer. 2024 Nov;212:114337. doi: 10.1016/j.ejca.2024.114337. Epub 2024 Sep 26. Eur J Cancer. 2024. PMID: 39357276 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,935 results

Search Page

Filters